An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...

The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023.  The ...

Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...

A recent study published in Cell Reports Medicine has identified distinct microbial signatures within the oral cavity and gut ...

An artificial intelligence (AI) model developed by researchers at The University of Texas MD Anderson Cancer Center ...

Researchers at City of Hope, a cancer research and treatment organization, and the University of California, Berkeley, have created a novel microfluidic platform that can assess women's breast cancer ...

Rectal cancer deaths among millennials under 45 are rising 2–3 times faster than colon cancer. Doctors urge early symptom ...

Device developed at the University of São Paulo aims to enable rapid and accessible diagnosis of pancreatic cancer, thereby increasing the chances of effective treatment.

Researchers developed a blood test to detect glioblastoma early with high accuracy, offering a faster, non-invasive ...

More than 174,000 Participants Enrolled Across Both Studies, Demonstrating the Scientific Rigor of Galleri® Clinical Development Program ...